248 related articles for article (PubMed ID: 23457809)
1. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
Mutihir JT; Nyango DD
East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
[TBL] [Abstract][Full Text] [Related]
2. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
Mutihir JT; Daru PH
Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
[TBL] [Abstract][Full Text] [Related]
3. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
Aisien AO; Enosolease ME
Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and clinical safety of Implanon.
Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
[TBL] [Abstract][Full Text] [Related]
5. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
6. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
[TBL] [Abstract][Full Text] [Related]
7. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
Graesslin O; Korver T
Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
[TBL] [Abstract][Full Text] [Related]
8. [Insertion problems, removal problems, and contraception failures with Implanon].
Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F; Llabres S; Autret-Leca E;
Gynecol Obstet Fertil; 2005 Dec; 33(12):986-90. PubMed ID: 16321557
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
[TBL] [Abstract][Full Text] [Related]
10. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.
Ezegwui HU; Ikeako LC; Ishiekwene CI; Oguanua TC
Niger J Med; 2011; 20(4):448-50. PubMed ID: 22288321
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive implants.
Ladipo O; Coutinho EM
Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
[TBL] [Abstract][Full Text] [Related]
12. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
[TBL] [Abstract][Full Text] [Related]
13. Indications for removal of intrauterine contraceptive devices in Jos, north-central Nigeria.
Mutihir JT; Ujah IA; Uduagbamen PF; Iranloye T
Niger J Clin Pract; 2006 Dec; 9(2):105-8. PubMed ID: 17319339
[TBL] [Abstract][Full Text] [Related]
14. Experience with Norplant at a Nigerian teaching hospital.
Mutihir JT; Aisien AO; Ujah IA
East Afr Med J; 2010 Nov; 87(11):456-60. PubMed ID: 23457808
[TBL] [Abstract][Full Text] [Related]
15. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
[TBL] [Abstract][Full Text] [Related]
16. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
Teunissen AM; Grimm B; Roumen FJ
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
[TBL] [Abstract][Full Text] [Related]
17. Implanon: a new contraceptive implant.
Fischer MA
J Obstet Gynecol Neonatal Nurs; 2008; 37(3):361-8. PubMed ID: 18507609
[TBL] [Abstract][Full Text] [Related]
18. One year study of Implanon on the adverse events and discontinuation.
Chaovisitsaree S; Piyamongkol W; Pongsatha S; Morakote N; Noium S; Soonthornlimsiri N
J Med Assoc Thai; 2005 Mar; 88(3):314-7. PubMed ID: 15962637
[TBL] [Abstract][Full Text] [Related]
19. Association of body mass index with removal of etonogestrel subdermal implant.
Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
[TBL] [Abstract][Full Text] [Related]
20. Contraceptive implants.
McDonald-Mosley R; Burke AE
Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
